Sirtsei Pharmaceuticals, Inc.
Clinical trials sponsored by Sirtsei Pharmaceuticals, Inc., explained in plain language.
-
New depression drug enters major testing phase
Disease control Recruiting nowThis study is testing whether an experimental medication called SP-624 can help reduce symptoms of major depression in adults. About 456 participants will be randomly assigned to receive either SP-624 or a placebo pill, and neither they nor the doctors will know which one they ge…
Phase: PHASE2 • Sponsor: Sirtsei Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scientists use AI to map Brain's response to new depression drug
Knowledge-focused Recruiting nowThis early-stage study aims to understand if an investigational drug called SP-624 changes brain activity patterns in healthy adults and people with major depression. Researchers will use a special cap to measure brain waves and AI software to analyze them. The study will also ch…
Phase: PHASE1 • Sponsor: Sirtsei Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC